Amplitude Surgical - Consolidated Annual Sales of €106.0m, up +6.3% at Constant Exchange Rates

• Growth of 7.0% at constant exchange rates in the fourth quarter of FY 2023-2024 and 6.3% for the full year
• 5.0% sales growth in France
• Good momentum outside France, with sales up 9.9% at constant exchange rates

VALENCE, France--(BUSINESS WIRE)--Regulatory News:

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its consolidated sales for fiscal year 2023-24.

Olivier Jallabert, Chief Executive Officer of Amplitude Surgical, comments: "Group sales for the 2023-24 financial year were up +6.3% at constant exchange rates on the previous year. Amplitude Surgical has thus recorded another year of business growth, both in France, with a +5.0% increase in sales, and internationally, where sales momentum is up +9.9% at constant exchange rates".

Consolidated sales for the 2023-2024 financial year

Sales 2023-24	30/06/2024	30/06/2023	Change at current exchange rates	Change at constant exchange rates
In € thousands - IFRS
Knee and hip activities	106,029	100,201	5.8%	6.3%
Total	106,029	100,201	5.8%	6.3%

Sales Q4 2023-24	30/06/2024	30/06/2023	Change at current exchange rates	Change at constant exchange rates
In € thousands - IFRS
Knee and hip activities	26,416	24,784	6.6%	7.0%
Total	26,416	24,784	6.6%	7.0%

In the 2023-24 financial year, Amplitude Surgical sales came to €106.0 million, up 5.8% and 6.3% at constant exchange rates.

The Group's business growth is slightly below the 7% announced in April 2024, as the last few months of activity in France were punctually negatively impacted by strikes in some private clinics, as well as by a drop in scheduling in the weeks preceding the elections.

In FY 2023-24, sales in France rose by 5.0%, while international distributors grew by 7.4% and the Group's international subsidiaries by 8.1% at current exchange rates and 10.7% at constant exchange rates.

Amplitude Surgical's direct sales (French market and international subsidiaries), which account for almost 93% of total Group sales, rose by +6.3% at constant exchange rates.

In France, the Group benefited from a favorable sales momentum throughout the year, except in the last quarter. France accounts for around 72% of Group sales.

For international subsidiaries, sales were up at constant exchange rates in Belgium, Australia and Brazil, while sales in Switzerland and South Africa were down.

Next press release:

Annual results 2023-24: Wednesday, October 23, 2024, after market close.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player in the global market for orthopedic surgical technologies for the lower limbs. Amplitude Surgical develops and markets high-end products for orthopedic surgery, covering the main pathologies affecting the hip and knee. Working in close collaboration with surgeons, Amplitude Surgical develops numerous high value-added innovations to best meet the needs of patients, surgeons and care facilities. A leading player in France, Amplitude Surgical is expanding internationally through its subsidiaries and a network of agents and exclusive distributors in over 30 countries. At June 30, 2024, Amplitude Surgical had 428 employees and sales of nearly 106.0 million euros.